PSG Publishes Annual Drug Benefit Design Report for 2024 with Prescryptive as Sponsor

“Pharmaceutical Strategies Group (“PSG”), an EPIC company, released its annual Trends in Drug Benefit Design Report, sponsored by Prescryptive Health, detailing the trends and leading strategies for traditional drug benefits. The research provides valuable insights about drug benefit design and management.” Read the full press release.

Our CEO and co-founder, Chris Blackley, says: “As a healthcare technology company, we believe that empowering patients to make informed choices is critical to addressing some of the most difficult issues facing the industry today. We are energized to see results that indicate that employers and health plans are ready to drive patient-focused change and are open to adopting new approaches to improve medication access, affordability, and value.”

Download the full report at PSG >

Latest News

View all News